| BWAY Stock | | | ILA 1,761 34.00 1.89% |
Chairman
David Zacut is Chairman of the Board, Interim Chief Executive Officer of Brainsway since 2020.
| Age | 66 |
| Tenure | 4 years |
| Phone | (972) 2 582 4030 |
| Web | www.brainsway.com |
Brainsway Management Efficiency
The company has return on total asset
(ROA) of
(0.0751) % which means that it has lost $0.0751 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.2021) %, meaning that it generated substantial loss on money invested by shareholders. Brainsway's management efficiency ratios could be used to measure how well Brainsway manages its routine affairs as well as how well it operates its assets and liabilities.
Brainsway has accumulated 672
K in total debt with debt to equity ratio
(D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Brainsway has a current ratio of 9.07, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Brainsway until it has trouble settling it off, either with new capital or with free cash flow. So, Brainsway's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brainsway sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brainsway to invest in growth at high rates of return. When we think about Brainsway's use of debt, we should always consider it together with cash and equity.
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. BRAINSWAY operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 100 people. Brainsway (BWAY) is traded on Tel Aviv Stock Exchange in Israel and employs 118 people.
Management Performance
Brainsway Leadership Team
Elected by the shareholders, the Brainsway's board of directors comprises two types of representatives: Brainsway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainsway. The board's role is to monitor Brainsway's management team and ensure that shareholders' interests are well served. Brainsway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainsway's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Avner Lushi, Director | |
| Gavriel Magen, Director | |
| Rami Itselev, Internal Auditor | |
| Karen Sarid, Director | |
| Moria Ankri, VP RD | |
| Hila Rubinshtein, Managing Director of Quality Control | |
| Menachem Esq, Gen VP | |
| Hadar Levy, Senior Vice President, General Manager of North America | |
| Richard Areglado, VP CFO | |
| Christopher Jako, President, Chief Executive Officer | |
| Uri Elmaliach, Director | |
| Abraham Zangen, Director | |
| Daniel Azriel, Director | |
| David Zacut, Chairman of the Board, Interim Chief Executive Officer | |
| Ety Rayten, External Director | |
| Pr Zangen, Member CoFounder | |
| Amit Jino, Clinical Experiment Coordinator | |
| Yosef Shalom, Director | |
| Avner Hagai, Co-Chairman of the Board | |
| Christopher Boyer, Vice President - Global Marketing | |
| Yiftach Roth, Chief Scientific Officer | |
| Aron Tendler, Chief Officer | |
| Ronen Segal, Vice President - Research & Development | |
| Orly Uri, Director | |
| Judith Huber, Chief Financial Officer, Senior Vice President | |
Brainsway Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainsway a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Information and Resources on Investing in Brainsway Stock
When determining whether Brainsway offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainsway's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For information on how to trade Brainsway Stock refer to our
How to Trade Brainsway Stock guide.
You can also try the
Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Please note, there is a significant difference between Brainsway's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainsway is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainsway's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.